The strategy of engineering patients’ own T cells for cancer therapy got two major endorsements in late August, one financial and one regulatory…
Para acessar a publicação na íntegra clique aqui
The strategy of engineering patients’ own T cells for cancer therapy got two major endorsements in late August, one financial and one regulatory…
Para acessar a publicação na íntegra clique aqui